Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
This article is authored by guest blogger, Jill Harris, Senior Director, Network Development at Coventry, a part of Mitchell | Genex | Coventry
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
The quarterly LOR summary is produced by
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
As 2020 began, a persistent opioid overdose epidemic was near the forefront of a list of national concerns in the United States.
The Sounding Board recently met with Kate Farley-Agee, our Vice President of Network Products at Coventry, and Tammy Bradly, our Vice President of